[
THE INVESTOR]
Celltrion announced on Sept. 9 that CT-P23, its antibody to treat seasonal flu, has obtained a US patent.
This antibody neutralizes Influenza A virus and is effective in diagnosis, prevention and treatment of the virus, the biopharmaceutical company explained.
By Hwang You-mee (
glamazon@heraldcorp.com)
![[Herald Interview] 'Trump will use tariffs as first line of defense for American manufacturing'](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=645&simg=/content/image/2024/11/26/20241126050017_0.jpg&u=20241126161719)
![[Health and care] Getting cancer young: Why cancer isn’t just an older person’s battle](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=645&simg=/content/image/2024/11/26/20241126050043_0.jpg&u=20241126145342)